Tevogen Inc. Common Stock
TVGN
44 hedge funds and large institutions have $2.49M invested in Tevogen Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 18 increasing their positions, 7 reducing their positions, and 5 closing their positions.
180% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 5
157% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 7
26% more funds holding
Funds holding: 35 → 44 (+9)
20% more capital invested
Capital invested by funds: $2.08M → $2.49M (+$408K)
0.04% less ownership
Funds ownership: 0.07% → 0.03% (-0.04%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$483K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$227K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$140K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$135K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$70.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PGA
Portland Global Advisors
Portland,
Maine
|
-$683K |
| 2 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$581K |
| 3 |
CF
Cantor Fitzgerald
New York
|
-$222K |
| 4 |
New York State Common Retirement Fund
Albany,
New York
|
-$156K |
| 5 |
HIM
HGC Investment Management
Toronto,
Ontario, Canada
|
-$82.2K |
TVGN Hedge Fund Activity: Q4 2024 in Review
44 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Tevogen Inc. Common Stock (TVGN) for Q4 2024, worth a combined $2.49M — up 20% from $2.08M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new TVGN positions and 5 closed out — a net gain of 9 holders — while 18 added to existing stakes and 7 trimmed.
The largest buyer was BlackRock, adding an estimated $483K. The largest seller was Portland Global Advisors, exiting entirely with an estimated $683K sold.
- 44 institutional investors held Tevogen Inc. Common Stock (TVGN) as of Q4 2024, up from 35 in Q3 2024.
- Funds reported $2.49M of Tevogen Inc. Common Stock stock for Q4 2024, up 20% quarter-over-quarter.
- 14 funds opened new Tevogen Inc. Common Stock positions in Q4 2024 and 5 closed out, a net change of +9 holders.
- The largest Tevogen Inc. Common Stock buyer in Q4 2024 was BlackRock, an estimated $483K added.
- The largest Tevogen Inc. Common Stock seller in Q4 2024 was Portland Global Advisors, an estimated $683K sold.
Based on aggregated 13F filings for Q4 2024.